RXO, Inc. logo RXO - RXO, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 5
HOLD 13
SELL 3
STRONG
SELL
0
| PRICE TARGET: $25.91 DETAILS
HIGH: $35.00
LOW: $18.00
MEDIAN: $28.00
CONSENSUS: $25.91
UPSIDE: 25.41%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Cyclical & Capital-Intensive 80% confidence

Primary model: Normalized Earnings × Cycle Multiple

Valuation Signal Overvalued Strong
Trading 1557.0% above fair value
Current Price $20.66
Bear Case $0.91 95.6% downside ($0.91 - $20.66) / $20.66 = -95.6% $0.23 × 4x
Fair Value $1.25 94.0% downside ($1.25 - $20.66) / $20.66 = -94.0% $0.23 × 6x
Bull Case $1.59 92.3% downside ($1.59 - $20.66) / $20.66 = -92.3% $0.23 × 7x

Adjust Assumptions

5.5x
0.23$

Key Value Driver

Through-cycle normalized EPS ($0.23)

Implied Market Multiple 91.1x

Plain-Language Summary

Using 7-year normalized EPS of $0.23 at a 6x cycle multiple, the base-case value is $1.25 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (21 analysts) $25.91
Analyst Range $18.00 – $35.00
Divergence from AlphaVal 95%

Warnings

This company has a built-in lending arm whose debt is mixed in with the main business. We capped the debt adjustment to avoid overstating what the core business owes.
Wall Street's average price target is $25.91 (from 21 analysts). Our estimate is 95% below the consensus -- consider that gap carefully.

Key Risks

  • Standard 10-year DCF produces unreliable terminal values for cyclicals
  • 'Cheap' P/E at cycle peak is the most common value trap — normalize first
  • Captive finance subsidiaries have different risk profiles from manufacturing